European Study of POBA Versus Cotavance(R) Paclitaxel Coated Balloon for the Treatment of Infrapopliteal Lesions in Critical Limb Ischemia (EURO CANAL)

NCT01260870 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

44

Enrollment

INDUSTRY

Sponsor class

Stopped Bayer terminated the program and sold the IP to Medronic

Conditions

PAD
Infrapopliteal Lesions

Interventions

DEVICE: Cotavance Paclitaxel Coated Balloon
DEVICE: Standard balloon angioplasty

Sponsor

Bayer